New technology can detect tiny ovarian tumors
“Synthetic biomarkers” could be used to diagnose ovarian cancer months earlier than now possible.
“Synthetic biomarkers” could be used to diagnose ovarian cancer months earlier than now possible.
Differences in chromosome number may underlie variation among genetically identical individuals.
Researchers program RNA nanoparticles that could protect against the virus.
Selectively blocking immune cells can prevent formation of scar tissue around medical devices.
New strategy could improve performance of some immune-based drugs.
Talented high school researchers attending the annual AAAS/AJAS conference in Boston meet with MIT faculty.
New method could enable pinpoint diagnostics on individual blood cells.
New sensor could reveal the neurotransmitter’s role in learning and habit formation.
MIT professor and NAS report committee co-chair Richard Hynes gives insight into the report’s recommendations.
Bill and Melinda Gates Foundation awards MIT, University College London, and University of Kansas $17.6M for development and production of low-cost vaccines.
Researchers discover a drug combination that can regenerate hair cells in the inner ear.
Takeda's $1 million gift to the MIT Koch Institute will advance research into how the immune system affects cancer.
Portable tool could help scientists learn more about cells’ roles in many diseases.
New members have made advances in artificial skin, wireless communications, nanotechnology, hydrology, and cancer treatment.
New test helps identify particles for gene delivery or RNA interference.